Endometriosis

Endometriosis experts describe the considerations of selecting a therapy for patients who are suffering from endometriosis.

A panel of experts provide an overview of first-line treatments for endometriosis treatment.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the multidisciplinary approach and shared decision-making strategies associated with endometriosis treatment.

Hugh Taylor, MD, along with a panel of experts, discuss the different challenges of diagnosing endometriosis as well as explaining why there is commonly a delay in diagnosis.

Endometriosis experts describe the potential physical, social, and psychological impact the disease may have on patients lives.

A panel of experts provide an overview of the health complications that are associated with endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the 3 main types of endometriosis and the commonly associated symptoms and risk factors.

Hugh Taylor, MD, leads a discussion with a panel of experts about the prevalence of endometriosis.

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

Women with endometriosis had a 34% greater risk of stroke than women without the chronic inflammatory gynecological condition, according to an analysis of the Nurses Health Study II.

A review of magnetic resonance imaging (MRI) for diagnosing endometriosis and related diseases in the Korean Journal of Radiology has found that the medical imaging technique can help in the early and accurate diagnosis of ovarian endometriotic cysts and deep infiltrating endometriosis (DIE), while avoiding the need for invasive procedures and radiation exposure, due to MRI’s high contrast and objectivity.

Most studies conclude that dietary interventions positively impact endometriosis, according to a systematic review in the journal Reproductive Sciences.

A study published in Cannabis and Cannabinoid Research found that women often used cannabis to manage endometriosis symptoms during the COVID-19 pandemic.

Rates of endometriosis are generally higher in leaner women, yet there still seems to be a connection between the presence and placement of fat tissue and the development of endometriosis. One study team sought to find out why.

A preprogrammed, nomad, easy-to-use, transcutaneous electrical nerve stimulation (TENS) device was well tolerated and provided rapid and lasting pain decrease in women with primary dysmenorrhea (PD), according to a study published in the journal Progrés en Urologie.

A study published in the Journal of Clinical Medicine highlights the high burden of endometriosis, including infertility, comorbidities, health care usage, and medical costs.

An expert reproductive endocrinologist explores the future treatment landscape for patients with endometriosis.

Hugh Taylor, MD, provides insight on remaining gaps in care in the endometriosis treatment landscape.

Dr Hugh Taylor discusses his treatment approach for patients with presumed endometriosis.

An expert in reproductive endocrinology reviews endometriosis treatment options for various patient populations, including patients with infertility, endometriomas, deep endometriosis, and effects on nonreproductive organs.

Dr Robert N. Taylor provides insight on emerging treatments and integrative therapies on the horizon with elagolix as well as real-world challenges using elagolix for endometriosis management.

Robert N. Taylor, MD, PhD, discusses key findings from clinical trial data on the dosing, pain relief profile, and adverse events of elagolix for patients with endometriosis.

An expert reproductive endocrinologist comments on the patient selection of aromatase inhibitors and the role of selective estrogen receptor modulators (SERMs) for endometriosis treatment.

Dr Robert N. Taylor examines the use of GnRH receptor antagonists, including elagolix, for the management of endometriosis.

Robert N. Taylor, MD, PhD, reviews first- and second-line therapies for the treatment of endometriosis.

An expert in reproductive endocrinology comments on the impact of endometriosis on a patient’s quality of life.

Dr Hugh Taylor highlights the importance of early detection of disease and the use of imaging technology in the diagnosis of endometriosis.

Hugh Taylor, MD, differentiates endometriosis from other disorders causing pelvic pain and shares common risk factors for the disease.

Women with surgically confirmed endometriosis were significantly more likely to report lower urinary tract symptoms (LUTSs) than those without, according to a study analysis in the journal Fertility and Sterility.